2029, Documentation and FDA - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2029

Documentation

FDA

A Temporary Extension for the Rare Pediatric Disease Priority Review Voucher with a Longer-Term Extension in Sight?

The FDA Law Blog

OCTOBER 13, 2024

A very important aspect of the program is that it costs FDA, and the government, no additional dollars, though we do not wish to minimize the additional resources a priority review demands over the standard review that such an application might otherwise receive.

Documentation

Documentation FDA

Is there a generic for Linzess? Availability, timeline, and cost

The Checkup by Singlecare

APRIL 15, 2025

Linzess is FDA approved for chronic idiopathic constipation. For a complete list of adverse reactions, see the medications FDA label. People may also take it if they have IBS-C, irritable bowel syndrome with constipation. According to a 2017 Ironwood press release containing forward-looking statements, about 1.5 take this medication.

Dosage

Dosage Insurance Adverse Reactions Insurance Coverage

A Temporary Extension for the Rare Pediatric Disease Priority Review Voucher with a Longer-Term Extension in Sight?

Is there a generic for Linzess? Availability, timeline, and cost

Stay Connected